James Lovgren Email & Phone Number

United States

Aspiro Therapeutics is on a mission to revolutionize treatment for obstructive lung diseases by mimicking the protective power of CC16, a natural lung protein vital for healthy breathing. We are focused on developing advanced, disease-modifying therapies that target the underlying mechanisms of conditions like asthma and COPD, going beyond symptom relief.

Phoenix, Arizona, US

The Cancer Fund (CF) is the first early-stage impact venture capital fund designed to impact cancer by commercializing promising cancer research for preventions, therapies, cures, and enabling technologies.◆ Advise and counsel on potential Life Science and Healthcare investment opportunities◆ investments range from pre-seed to later stages to manage risk.

New York City, US

MBX is a venture capital partnership investing in good health, for everyone. At MBX, our investment team focuses on early-stage healthcare, medical device, and biotech companies.◆ Advise and counsel on potential Life Science and Healthcare investment opportunities◆ Seed through Series B investments in life sciences/healthcare startups

Results-driven consultancy focused on delivering tangible outcomes for your life sciences business. Expertise in strategic planning, marketing, product management & commercialization, and business development that drives innovation and growth. Let's collaborate to develop comprehensive strategies, launch impactful products, and propel your business forward.

Rockville, Maryland, US

(NASDAQ: MXCT) At MaxCyte, we pursue cell engineering excellence to maximize the potential of cells to improve patients’ lives. We have spent more than 20 years honing our expertise by building best-in-class platforms, perfecting the art of the transfection workflow, and venturing beyond today’s processes to innovate tomorrow’s solutions.

Emeryville, CA, US

(NASDAQ: BLI) The Opto™ Cell Therapy Development Workflow accelerates the creation of better therapeutics by enabling multiple functional assays to be performed simultaneously on 1000s of individual T cells in a matter of days. Deeply characterize, profile, and map your T cell populations at the single-cell level to directly link behavior to gene expression.

Waltham, MA, US

Director, Product Management 2018 - 2019(NYSE: TMO) Bringing a cell or gene therapy to market is a monumental endeavor that requires commitment, dedication, and a lot of science. This work holds the potential to deliver life-changing treatments—Our mission is to help researchers succeed by providing high-quality materials, services, and support to help.

Waltham, MA, US

Minerva Biotechnologies is developing therapies for curing cancers and commercializing core technology that will enable next-generation stem cell therapies. Both flow from Minerva’s fundamental discovery that both cancer cell and stem cell growth are mediated by the same two molecules: the growth factor NME-p and the growth factor receptor MUC1*◆ Developed.

ORIG3N develops novel approaches for drug efficacy screening and human healthcare utilizing Induced Pluripotent Stem Cells (iPSCs). We deliver products and services to the healthcare marketplace as well as technologies for biotechnology and pharmaceutical research and development.◆ Responsible for ensuring the commercial success of ORIG3N's stem cell.

Waltham, MA, US

- Thermo Fisher Scientific Acquired Life Technologies in Feb 2014 - Thermo Fisher Scientific is the world leader in serving science, with revenues of $17 billion and 50,000 employees in 50 countries. Our mission is to enable our customers to make the world healthier, cleaner and safer.Lead product management of a $70M+ global cell biology portfolio.

Waltham, MA, US

Life Technologies is a global biotechnology tools company dedicated to improving the human condition. The PSCS division provides innovative, biologically relevant systems that are representative of in vivo systems for major research and disease areas. Our products enable faster discovery and development of safer and more effective medicines.Lead product.

Waltham, MA, US

The ADME/Tox division provides innovative cell-based products and services to accelerate the development of safe, effective drugs and ensure the safety of all types of chemical compounds. Through internal research and collaboration, we work to extend the utility, reproducibility, viability and predictability of hepatic and other in vitro models.

US

► Senior Product Manager (March 2008 - September 2008)► Product Manager (May 2006 - February 2008) Cogenics provides the broadest range of genomics services for both research and regulated projects, including services to support clinical trials, molecular diagnostics, pharmacogenomic discovery, validation, and biomarker research. Services include.

Wake Forest, NC, US

Synthonix specializes in the synthesis of small molecule heterocycles designed with biological and pharmacological bias. Synthonix offers powerful molecules tailored to participate in proven chemical reactions such as Horner-Wadsworth-Emmons coupling, Suzuki and Stille coupling, condensations, cycloadditions, and many others.

New York, NY, US

Summit Pharmaceuticals is a sourcing partner for major pharmaceutical corporations utilizing a global network of pharma experts and local market knowledge to offer the best solutions to save cost and time in drug development. Areas of expertise include sourcing of chemical intermediates, active pharmaceutical ingredients and development of new suppliers.

Master Of Business Administration (Mba), Finance

Bachelor Of Science (Bs), Biology

Executive Strategy Program

Executive Education, Innovation For Growth: Strategies And Best Practices

Certificate Of Specialized Studies, Integrated Marketing

Executive Education, Negotiation Skills For Effective Managers